Pull the syringe to:
(0.100ml)
Concentration: 5.00 mg/ml
Doses per vial: 30
This calculator is provided as a reference tool for research purposes only. Always follow your institution’s safety protocols when handling research compounds.
GHK-Cu 50mg is a copper-binding research peptide complex studied in relation to extracellular matrix research, skin pathway research, wound-response models, tissue-remodelling research, copper transport biology and oxidative stress pathway models.
GHK-Cu is commonly described as a copper complex of the tripeptide glycyl-L-histidyl-L-lysine, also known as GHK. Research literature describes GHK-Cu as a multifunctional copper peptide with interest across tissue repair, extracellular matrix remodelling, inflammatory pathway regulation and redox biology.
This product is supplied for laboratory research use only. It is not a medicine, cosmetic product, skincare product, injectable product, wound-healing product, anti-ageing product, hair growth product or supplement for human use.
| Product Detail | Information |
|---|---|
| Product name | GHK-Cu |
| Common research names | Copper peptide GHK-Cu, Cu-GHK, glycyl-L-histidyl-L-lysine copper complex |
| Size | 50mg |
| Product type | Copper peptide research compound |
| Research category | Skin Research / Tissue Remodelling Research / Copper Peptide Research |
| Common research interest | Extracellular matrix, collagen pathway models, wound-response research, copper biology and oxidative stress pathway research |
| Peptide type | Copper-bound tripeptide complex |
| Parent peptide | Glycyl-L-histidyl-L-lysine, also known as GHK |
| Form | Lyophilised powder or supplier-specific research preparation |
| Intended use | Laboratory research only |
| Human use | Not for human consumption, cosmetic use, topical use, wound care, hair growth, administration or injection |
| Documentation | Certificate of Analysis should be checked before use |
| Component | Research Class | General Research Role |
| GHK | Tripeptide | Glycyl-L-histidyl-L-lysine peptide sequence studied in copper-binding research |
| Copper ion | Metal coordination component | Studied in relation to copper-dependent biological signalling and redox pathway research |
| GHK-Cu complex | Copper peptide complex | Studied in extracellular matrix, wound-response, skin and tissue-remodelling pathway models |
| Glycine | Amino acid component | Part of the GHK tripeptide sequence |
| Histidine | Amino acid component | Important in copper coordination research because of its imidazole side chain |
| Lysine | Amino acid component | Part of the GHK tripeptide sequence |
| Molecular formula | Supplier and listing dependent | PubChem lists separate GHK-Cu and Cu-GHK entries, so CoA confirmation is important |
| Lyophilised preparation | Freeze-dried research format | Supports stability before laboratory preparation when stored correctly |
PubChem contains GHK-Cu and Cu-GHK compound entries, with GHK-Cu listed as C28H48CuN12O8 and Cu-GHK listed as C14H24CuN6O4. Because copper peptide listings can vary by complex form and supplier documentation, product identity, copper content, salt form, purity and batch information should always be confirmed through the Certificate of Analysis.
GHK-Cu is studied as a copper peptide complex. In research models, it is commonly examined for its relationship with extracellular matrix signalling, collagen-related pathway models, wound-response research, tissue-remodelling biology, inflammatory pathway research and oxidative stress response.
A PubMed Central review describes GHK-Cu research in relation to protective and regenerative actions in human skin research and discusses gene expression data as part of the proposed mechanisms behind these effects. This should be understood as research literature context only, not as a claim that a research-use GHK-Cu 50mg vial is approved, safe or effective for human skin, wound healing, cosmetic, hair growth or anti-ageing use.
| Research Area | GHK-Cu |
| Main research category | Copper peptide research |
| Parent peptide | Glycyl-L-histidyl-L-lysine |
| Metal component | Copper |
| Peptide length | Tripeptide |
| Common pathway interest | Extracellular matrix, collagen pathway and tissue-remodelling research |
| Skin research interest | Skin cell models, dermal pathway research and gene expression models |
| Wound-response interest | Preclinical wound-response and tissue-repair pathway research |
| Oxidative stress interest | Copper biology, redox signalling and oxidative stress pathway models |
| Evidence limitation | Laboratory, preclinical, cosmetic science and limited translational research contexts |
| Product limitation | Research use only, not approved for human use |
| Feature | GHK-Cu | GHK |
| Product class | Copper-bound peptide complex | Parent tripeptide |
| Main components | GHK peptide plus copper | Glycyl-L-histidyl-L-lysine |
| Common research focus | Copper peptide signalling, extracellular matrix and tissue-remodelling models | Peptide signalling and copper-binding precursor research |
| Copper status | Copper-complexed form | Not necessarily copper-bound unless complexed |
| Common SEO risk | Being marketed as skincare, hair growth or anti-ageing | Being marketed as a cosmetic peptide |
| Safer positioning | Copper peptide research compound | Tripeptide research compound |
| Feature | GHK-Cu | GHK Basic |
| Research class | Copper peptide complex | Non-copper or parent peptide form, depending on supplier |
| Main research interest | Copper coordination, extracellular matrix and skin pathway research | Parent peptide and copper-binding comparison research |
| Colour expectation | Often blue due to copper complexation | May not have the same copper-complex appearance |
| Product verification | Requires copper content and identity confirmation | Requires sequence and identity confirmation |
| Human-use claim | Not appropriate | Not appropriate |
| Feature | GHK-Cu | BPC-157 |
| Research class | Copper-bound tripeptide complex | Stable gastric pentadecapeptide research peptide |
| Main research focus | Skin pathway, extracellular matrix and tissue-remodelling research | Gastric peptide, cytoprotection and tissue-response pathway research |
| Peptide length | Tripeptide complex | 15-amino-acid peptide |
| Common overlap | Wound-response and tissue-remodelling research models | Wound-response and soft tissue pathway research models |
| Common SEO risk | Skincare, anti-ageing and hair growth claims | Injury recovery and gut-healing claims |
| Safer positioning | Copper peptide and extracellular matrix research | Gastric pentadecapeptide research |
| Strength | Product Page Positioning |
| GHK-Cu 50mg | Standard research amount for copper peptide pathway and extracellular matrix research |
| GHK-Cu 100mg | Higher research amount for larger protocol-specific concentration planning |
GHK-Cu strengths should be treated as product variants, not duplicate product pages. If multiple strengths are listed separately, each page should have a strength-specific title, meta description, slug, concentration table and internal links to reduce SEO cannibalisation.
| Common Online Claim | Safer Research-Use Wording |
| Anti-ageing | Studied in ageing-related skin pathway and extracellular matrix research models |
| Wrinkle reduction | Better framed as dermal matrix and collagen pathway research |
| Collagen boost | Better framed as collagen-related gene expression and extracellular matrix research |
| Hair growth | Not an approved or appropriate product claim |
| Skin repair | Better framed as wound-response and tissue-remodelling pathway research |
| Scar improvement | Not an approved or appropriate product claim |
| Wound healing | Studied in wound-response models, not a human-use claim |
| Cosmetic use | Not suitable for research-use product positioning |
GHK-Cu 50mg is not intended to diagnose, treat, cure or prevent any disease. It is not supplied for skincare, anti-ageing, wrinkle reduction, collagen boosting, wound healing, scar treatment, hair growth, cosmetic use, topical application, injection, supplementation, tissue repair, general wellness or therapeutic use.
All information on this page is provided for laboratory research and product handling context only.
There is no universal recommended dilution for GHK-Cu 50mg. Dilution depends on the research protocol, required working concentration, assay design, solvent compatibility, copper complex form, storage method and validated laboratory procedure.
Because GHK-Cu is a copper peptide complex, researchers should confirm solvent compatibility, pH conditions, copper stability and assay suitability through the Certificate of Analysis, SDS and validated research protocol.
For research concentration planning only, the basic formula is:
Total peptide complex amount divided by diluent volume equals final concentration.
| Diluent Added to 50mg Vial | Final Concentration |
| 1mL | 50mg/mL |
| 2mL | 25mg/mL |
| 5mL | 10mg/mL |
| 10mL | 5mg/mL |
| 20mL | 2.5mg/mL |
| 25mL | 2mg/mL |
| 50mL | 1mg/mL |
These are research concentration examples only. They are not human dosing instructions and must not be used to calculate injection quantities, topical quantities or cosmetic formulation directions.
Before handling GHK-Cu 50mg in a laboratory setting, make sure all materials, documentation and clean handling conditions are prepared.
| Item | Purpose |
| Product vial | Contains GHK-Cu copper peptide research compound |
| Certificate of Analysis | Confirms batch-level testing information |
| SDS or safety documentation | Provides handling, hazard and disposal guidance |
| Copper content or identity documentation | Helps confirm the product is the intended copper peptide complex |
| Suitable research-grade diluent | Used to prepare a working research solution if compatible |
| Sterile or clean lab consumables | Helps reduce contamination and cross-contamination risk |
| Personal protective equipment | Gloves, lab coat and eye protection |
| Alcohol wipes or approved disinfectant | Used for surface and vial-top preparation |
| Laboratory labels | Records concentration, date, batch and handler details |
| Controlled storage access | Supports correct storage after preparation |
| Disposal container | Used for compliant laboratory waste disposal |
The following is a general laboratory handling framework only. Always follow the product Certificate of Analysis, supplier documentation, SDS, institutional procedures and validated research protocol.
Check the product label, batch number, Certificate of Analysis, SDS, copper complex details and storage requirements before handling the vial.
Use a clean laboratory workspace. Wear appropriate PPE and disinfect the bench surface, vial top and any required equipment.
Do not assume every peptide diluent is suitable for a copper peptide complex. Confirm compatibility through supplier documentation, SDS and the approved research protocol.
If the vial has been stored cold, allow it to equilibrate according to laboratory procedure before opening or reconstitution. Avoid condensation entering the vial.
Add the selected research-grade diluent slowly down the inside wall of the vial. Avoid forceful spraying directly onto the lyophilised powder.
Gently swirl or roll the vial until the powder is dissolved. Avoid aggressive shaking, unnecessary vortexing or foaming unless a validated protocol specifically allows it.
Check the solution for unexpected cloudiness, visible particles, unusual colour changes, precipitation or undissolved material. If anything appears abnormal, quarantine the vial and check supplier documentation.
Label the vial or aliquots with the product name, concentration, diluent used, date prepared, batch number and researcher initials. Store according to the validated protocol as soon as possible.
Some copper peptide complexes may require protocol-specific handling. Dissolution should always be handled gently and according to laboratory documentation.
| Issue | What It May Indicate | Safer Response |
| Powder clinging to vial wall | Static or lyophilisation residue | Allow more contact time with diluent |
| Small particles remain | Incomplete hydration or concentration issue | Continue gentle mixing and check protocol |
| Cloudy solution | Possible incompatibility or contamination | Stop and check documentation |
| Precipitation appears | Possible pH, solvent or concentration incompatibility | Quarantine and reassess preparation method |
| Unexpected colour change | Possible degradation, oxidation or contamination | Do not continue without supplier guidance |
| Product identity unclear | Possible GHK/GHK-Cu confusion | Stop and confirm CoA before using |
| Storage Factor | Guidance |
| Product form | Lyophilised powder or supplier-specific dry preparation |
| Storage condition | Follow supplier label, CoA and SDS |
| Light exposure | Protect from unnecessary light exposure |
| Moisture exposure | Keep sealed until use |
| Temperature changes | Avoid repeated temperature cycling |
| Handling | Minimise unnecessary opening or exposure |
| Variant control | Store and label separately from plain GHK or non-copper peptide products |
| Storage Factor | Guidance |
| Storage condition | Follow validated research protocol |
| Labelling | Record product name, concentration, diluent, date and batch number |
| Copper complex tracking | Record copper-complex form if documented |
| Freeze-thaw cycles | Avoid repeated freeze-thaw exposure |
| Aliquoting | Use small research aliquots where appropriate |
| Contamination control | Use clean laboratory technique |
| Light exposure | Protect from unnecessary light exposure where required |
| Disposal | Dispose according to laboratory waste procedures |
Copper peptide complexes may be sensitive to temperature, light, pH, oxidation, solvent conditions and contamination. Storage conditions should be confirmed through supplier documentation or the laboratory’s validated method.
This page does not provide human dosing, injection instructions, injection schedules, cosmetic-use instructions, topical-use directions or administration guidance.
GHK-Cu 50mg is not supplied for human or animal administration. It is a laboratory research-use product only.
For research settings, any measured aliquots should be prepared according to the concentration required by the approved research protocol. All calculations should be checked, documented and traceable.
| Planning Item | What to Record |
| Final concentration | Total GHK-Cu amount and diluent volume |
| Working solution | Concentration used in the research protocol |
| Aliquot volume | Volume transferred into each labelled lab tube |
| Batch details | Product batch, CoA and preparation date |
| Copper complex confirmation | Confirmation that the product is GHK-Cu, not plain GHK |
| Diluent or solvent | Exact diluent, solvent or vehicle used |
| Storage location | Fridge, freezer, desiccator or other controlled storage area |
| Handler details | Researcher name or initials |
| Preparation date | Date and time of reconstitution |
| Disposal date | When the aliquot should no longer be used |
| Strength check | Confirmation that the 50mg vial strength matches the approved research protocol |
Correct handling is important for research consistency, contamination control, copper complex stability and product traceability. Most mistakes occur when products are not labelled clearly, copper complex form is not confirmed, solvent compatibility is assumed, concentration calculations are not recorded or storage conditions are not followed.
Because GHK-Cu is commonly discussed online in relation to skincare, anti-ageing, collagen, wound healing and hair growth, product pages should avoid wording that could be interpreted as encouraging human self-use, injection, topical application, cosmetic use or therapeutic use.
| Always | Why It Matters |
| Check the Certificate of Analysis | Confirms batch-level information |
| Review SDS or safety documentation | Supports safe laboratory handling and disposal |
| Confirm copper peptide identity | Helps distinguish GHK-Cu from plain GHK |
| Confirm solvent compatibility | Helps avoid precipitation or invalid research preparation |
| Use PPE | Reduces contamination and exposure risk |
| Label every vial and aliquot | Prevents mix-ups |
| Record concentration calculations | Supports traceability |
| Use clean laboratory technique | Reduces contamination risk |
| Follow institutional protocols | Keeps handling consistent and auditable |
| Store according to documentation | Helps protect compound integrity |
| Dispose of lab waste correctly | Supports safety and compliance |
| Use research-use wording only | Reduces misleading human-use interpretation |
| Never | Why It Is Risky |
| Never use for self-injection | Product is research use only |
| Never use as a skincare ingredient | Product is not supplied as a cosmetic |
| Never apply topically | Product is not supplied for topical use |
| Never sell or promote as an anti-ageing product | Creates human-use and compliance risk |
| Never make wrinkle, collagen or skin-rejuvenation claims | Not an approved or appropriate product claim |
| Never make hair growth claims | Not an approved or appropriate product claim |
| Never make wound-healing or scar-treatment claims | Not suitable for a research-use product page |
| Never assume GHK-Cu is the same as plain GHK | Copper-complex status matters |
| Never assume purity without CoA | Batch quality must be documented |
| Never assume solvent compatibility | Copper complexes may behave differently from standard peptides |
| Never use a damaged or unlabelled vial | Identity and integrity may be uncertain |
| Never leave prepared solutions unlabelled | Creates traceability risk |
| Never rely on social media or cosmetic DIY protocols | They may be inaccurate, unsafe or non-compliant |
The table below is for concentration planning only. It does not represent dosage, injection quantity, topical-use quantity or cosmetic formulation guidance.
| Total Vial Amount | Diluent Volume | Final Concentration |
| 50mg | 1mL | 50mg/mL |
| 50mg | 2mL | 25mg/mL |
| 50mg | 5mL | 10mg/mL |
| 50mg | 10mL | 5mg/mL |
| 50mg | 20mL | 2.5mg/mL |
| 50mg | 25mL | 2mg/mL |
| 50mg | 50mL | 1mg/mL |
If a researcher adds 10mL of suitable research-grade diluent to a 50mg vial, the resulting concentration is 5mg/mL.
This calculation is for research concentration planning only. It is not a human or animal dosing example, topical-use example or cosmetic formulation instruction.
GHK-Cu is a copper peptide research compound made from the tripeptide glycyl-L-histidyl-L-lysine complexed with copper. It is studied in relation to extracellular matrix research, skin pathway models, wound-response research, tissue remodelling and copper biology.
GHK-Cu is commonly described as a copper-bound peptide complex. The parent peptide GHK is a tripeptide made from glycine, histidine and lysine.
No. GHK-Cu refers to the copper-complexed form, while GHK refers to the parent tripeptide. The CoA should be checked to confirm whether the product is GHK-Cu or a non-copper GHK product.
Copper peptide complexes are often associated with a blue colour due to copper coordination. The expected appearance should always be checked against supplier documentation and the Certificate of Analysis.
GHK-Cu is commonly studied in relation to extracellular matrix remodelling, collagen-related pathways, dermal cell research, wound-response models, inflammatory pathway regulation and oxidative stress pathway research. Research reviews discuss GHK-Cu in relation to skin research, gene expression and regenerative pathway models.
This research product is not approved or supplied for skincare, anti-ageing, wrinkle reduction, collagen boosting, hair growth, wound healing, topical application, injection or human use. It should be described only as a laboratory research product.
No. GHK-Cu is a copper peptide complex, while BPC-157 is a stable gastric pentadecapeptide research peptide. They may both appear in tissue-response research discussions, but they are chemically different products.
A Certificate of Analysis provides batch-level testing information. It helps researchers verify product identity, purity, copper complex form, salt form and quality documentation before use in a research setting.
| Resource | Why It Is Useful |
| PubChem GHK-Cu compound profile | Useful background on GHK-Cu identity and compound listing. |
| PubChem Cu-GHK compound profile | Useful background showing a separate Cu-GHK compound listing, reinforcing why CoA confirmation matters. |
| GHK-Cu regenerative and protective actions review | Useful background on GHK-Cu, skin research, protective actions and gene expression mechanisms. |
Research Use Only: GHK-Cu 50mg is supplied strictly for laboratory research purposes. It is not intended for human or animal consumption, injection, therapeutic use, cosmetic use, topical application, diagnostic use, skincare, anti-ageing, wrinkle reduction, collagen boosting, hair growth, wound healing, scar treatment, tissue repair, body enhancement or performance enhancement. Information on this page is provided for research education and product handling context only. Always follow applicable laws, institutional procedures, supplier documentation, SDS guidance and qualified laboratory protocols.
Find research peptides, certificate documentation, guides and key product categories in one clean menu.